Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 204 participants.
Also called NCT04844814
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 204 participants
- Registry
-
NCT04844814
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Suspended
Technical summary
Registry record NCT04844814. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-02 (actual); primary completion 2025-02-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
- Acronym
- Ana4CKD
- Condition
- Gout
- Condition
- Chronic Kidney Disease
- Condition
- Renal Transplantation
- Intervention (Drug)
- Anakinra 100Mg/0.67Ml Inj Syringe
- Intervention (Drug)
- Prednisone
- Intervention (Drug)
- Placebo of Prednisone
- Intervention (Drug)
- Placebo of Anakinra
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct04844814- Content hash
c1dca5e86b09b6ae96c22a575ef951c360e6c3454658d70ad10385efa045443c